ES2131527T3 - Anticuerpos monoclonales contra c-kit. - Google Patents

Anticuerpos monoclonales contra c-kit.

Info

Publication number
ES2131527T3
ES2131527T3 ES92910495T ES92910495T ES2131527T3 ES 2131527 T3 ES2131527 T3 ES 2131527T3 ES 92910495 T ES92910495 T ES 92910495T ES 92910495 T ES92910495 T ES 92910495T ES 2131527 T3 ES2131527 T3 ES 2131527T3
Authority
ES
Spain
Prior art keywords
dsm acc
kit
kit receptor
monoclonal antibodies
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92910495T
Other languages
English (en)
Inventor
Ilse Bartke
Gunter Kostka
Kurt Naujoks
Axel Ullrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Roche Diagnostics GmbH
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH, Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of ES2131527T3 publication Critical patent/ES2131527T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A ANTICUERPOS MONOCLONALES FRENTE A LOS RECEPTORES HUMANOS KIT-C QUE SE OBTIENEN DE LAS LINEAS DE CELULAS DSM ACC 2007, DSM ACC 2008 Y DSM ACC 2009 O EN MODO EQUIVALENTE SON CAPACES DE UNIRSE EN LOS RECEPTORES KIT-C COMO ANTICUERPOS PRODUCIDOS A PARTIR DE LINEAS DE CELULAS DSM ACC 2007, DSM ACC 2008 O DSM ACC 2009. UN ULTERIOR OBJETO DE LA INVENCION ES UN PROCEDIMIENTO PARA COMPROBAR LA INFLUENCIA MALIGNA DE TUMORES DE LAS CELULAS HEMATOPOYETICAS DE SEMINOMA O CARCINOMA DEL PULMON, SE INCUBAN PEQUEÑAS CELULAS EN UNA PRUEBA DE TEJIDO CON POR LO MENOS UNOS ANTICUERPOS MONOCLONALES CON ARREGLO A LA INVENCION FRENTE A RECEPTORES KIT-C Y A CONTINUACION SE COMPRUEBA EL ANTICUERPO UNIDO MEDIANTE METODOS CONOCIDOS.
ES92910495T 1991-05-25 1992-05-20 Anticuerpos monoclonales contra c-kit. Expired - Lifetime ES2131527T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4117090 1991-05-25
DE4205148A DE4205148A1 (de) 1991-05-25 1992-02-20 Monoklonale antikoerper gegen c-kit

Publications (1)

Publication Number Publication Date
ES2131527T3 true ES2131527T3 (es) 1999-08-01

Family

ID=25903908

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92910495T Expired - Lifetime ES2131527T3 (es) 1991-05-25 1992-05-20 Anticuerpos monoclonales contra c-kit.

Country Status (6)

Country Link
EP (1) EP0586445B1 (es)
JP (1) JPH0768279B2 (es)
AT (1) ATE177475T1 (es)
DE (2) DE4205148A1 (es)
ES (1) ES2131527T3 (es)
WO (1) WO1992021766A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600589C1 (de) * 1996-01-10 1997-01-16 Univ Eberhard Karls Antikörper A3C6E2
WO2008153926A2 (en) 2007-06-05 2008-12-18 Yale University Inhibitors of receptor tyrosine kinases and methods of use thereof
EP2668210B1 (en) 2011-01-26 2020-06-17 Celldex Therapeutics, Inc. Anti-kit antibodies and uses thereof
AR086044A1 (es) * 2011-05-12 2013-11-13 Imclone Llc Anticuerpos que se unen especificamente a un dominio extracelular de c-kit y usos de los mismos
EP2748197A2 (en) 2011-08-26 2014-07-02 Merrimack Pharmaceuticals, Inc. Tandem fc bispecific antibodies
AU2013295848B2 (en) 2012-07-25 2018-05-24 Celldex Therapeutics, Inc. Anti-KIT antibodies and uses thereof
KR20150143458A (ko) 2013-03-06 2015-12-23 메리맥 파마슈티컬즈, 인크. 항-C-MET 탠덤 Fc 이중특이적 항체
CN106659782B (zh) 2014-05-23 2021-11-09 塞尔德克斯医疗公司 一种用于嗜酸性粒细胞或肥大细胞相关病症治疗的抗体
PE20230376A1 (es) 2019-12-24 2023-03-06 Carna Biosciences Inc Compuestos moduladores de la diacilglicerol quinasa
US11692038B2 (en) 2020-02-14 2023-07-04 Gilead Sciences, Inc. Antibodies that bind chemokine (C-C motif) receptor 8 (CCR8)
EP4359415A1 (en) 2021-06-23 2024-05-01 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
CN117480155A (zh) 2021-06-23 2024-01-30 吉利德科学公司 二酰基甘油激酶调节化合物
CA3222439A1 (en) 2021-06-23 2022-12-29 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
WO2022271650A1 (en) 2021-06-23 2022-12-29 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
WO2023076983A1 (en) 2021-10-28 2023-05-04 Gilead Sciences, Inc. Pyridizin-3(2h)-one derivatives
CA3235986A1 (en) 2021-10-29 2023-05-04 Gilead Science, Inc. Cd73 compounds
AU2022417491A1 (en) 2021-12-22 2024-05-23 Gilead Sciences, Inc. Ikaros zinc finger family degraders and uses thereof
AU2022419982A1 (en) 2021-12-22 2024-06-06 Gilead Sciences, Inc. Ikaros zinc finger family degraders and uses thereof
TW202340168A (zh) 2022-01-28 2023-10-16 美商基利科學股份有限公司 Ｐａｒｐ７抑制劑
TW202346277A (zh) 2022-03-17 2023-12-01 美商基利科學股份有限公司 Ｉｋａｒｏｓ鋅指家族降解劑及其用途
TW202400138A (zh) 2022-04-21 2024-01-01 美商基利科學股份有限公司 Ｋｒａｓ ｇ１２ｄ調節化合物
WO2024006929A1 (en) 2022-07-01 2024-01-04 Gilead Sciences, Inc. Cd73 compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001973A2 (en) * 1987-09-02 1989-03-09 Applied Biotechnology, Inc. Recombinant pox virus for immunization against tumor-associated antigens

Also Published As

Publication number Publication date
DE59209650D1 (de) 1999-04-15
JPH06502545A (ja) 1994-03-24
ATE177475T1 (de) 1999-03-15
EP0586445B1 (de) 1999-03-10
DE4205148A1 (de) 1993-01-21
WO1992021766A1 (de) 1992-12-10
JPH0768279B2 (ja) 1995-07-26
EP0586445A1 (de) 1994-03-16

Similar Documents

Publication Publication Date Title
ES2131527T3 (es) Anticuerpos monoclonales contra c-kit.
ATE58554T1 (de) Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.
PT86792A (pt) Monoclonal antibodies against melanoma-associated antigens hybrid cell lines producing these antibodies and use therefor
DE122006000007I1 (de) Antigene epitope, die sich ausschlisslich auf ige-tragenden B-Lymphocyten befinden.
JPS56106154A (en) Detection method of hemoglobin in night soil
DE69521794D1 (de) Zellen mit mehreren geänderten epitopen auf einem oberflächeantigen zur verwendung in transplantation
NO159888C (no) Monoklonalt antistoff.
AU6600281A (en) Hybrid cell line
NO159887C (no) Monoklonalt antistoff.
NO172596C (no) Apolipoprotein b-spesifikke monoklonale antistoffer produsert av to nye hybridomer, anvendelse av disse og diagnostiske systemer inneholdende disse
DK314586A (da) Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler
ATE180974T1 (de) Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen
ATE71149T1 (de) Monoklonale antikoerper.
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
WO1987007302A3 (en) MONOCLONAL ANTIBODIES TO HUMAN LYMPHOCYTE IgE RECEPTORS, HYBRIDOMAS PRODUCING SUCH ANTIBODIES, AND KITS FOR USING SUCH ANTIBODIES
ATE56617T1 (de) Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung.
ZA866956B (en) Methods for utilizing cell lines which lack human class ii histocompatibility antigens
EP0248147A3 (en) Method of determining the presence of cancer cells
ES8609465A1 (es) Procedimiento para preparar nuevos anticuerpos monoclonales de raton con especificidad anti-interferon de humano
IT8821547A0 (it) Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.
Bongertz et al. Production of a monoclonal anti-hamster thymocyte antibody with mitogenic properties
SU1398393A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к микобактериям туберкулеза

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 586445

Country of ref document: ES